Home > Healthcare > Pharmaceuticals > Drug Delivery > Transdermal Drug Delivery Systems Market
Transdermal Drug Delivery Systems Market Size
- Report ID: GMI5548
- Published Date: Apr 2023
- Report Format: PDF
Transdermal Drug Delivery System Market Size
Transdermal Drug Delivery System Market size amassed over USD 29 billion in revenue in 2022. The industry is anticipated to witness over 8% CAGR between 2023 and 2032, owing to a remarkable surge in incidences of chronic ailments.
expenditure on health and boosted investments in R&D projects focused on enhancing medicine and route of administration. For instance, the Centers for Disease Control and Prevention data suggests that chronic diseases are one of the prime drivers of annual healthcare costs of $4.1 trillion in the U.S. These factors, in line with the continuous technological developments in the drug delivery system, will augment market share.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Transdermal Drug Delivery System Market Size in 2022: | USD 29 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 8% |
| 2032 Value Projection: | USD 61 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 195 |
| Tables, Charts & Figures: | 334 |
| Segments covered: | Type, Application, End-use and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
In contrast, the limited number of approved medications and transdermal drug delivery systems worldwide may hamper industry performance. Also, the transdermal treatment route is not considered suitable as it may cause drug irritation or skin sensitivity, hindering the market landscape. Alongside the development, recall, and failure of a transdermal drug delivery system (TDDS) associate high costs, which may further act as a growth restraint over the forecast timeframe.
Frequently Asked Questions (FAQ) :
Transdermal Drug Delivery System Market Scope
